Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA 94143-0856, USA.
Cancer Causes Control. 2013 May;24(5):979-88. doi: 10.1007/s10552-013-0173-5. Epub 2013 Feb 19.
Patient participation in cancer clinical trials is imperative to the advancement of medical science. Physicians play an important role in recruitment by discussing clinical trials with their cancer patients. Patient-physician discussion is influenced by many factors relating to the physician, the patient, and the healthcare system.
Physicians selected from the 2008-2009 American Medical Association Physician Masterfile who practiced in California, Florida, Illinois, or New York and specialized in medical oncology, surgery, or radiation oncology were surveyed about their attitudes and practices with respect to breast cancer clinical trials. Practice types were categorized according to the classifications provided by the American College of Surgeons, and clinical trial and practice addresses were geocoded.
Surveys were completed by 706 of 1,534 eligible physicians (46 %). Medical oncologists were more likely than surgical or radiation oncologists to discuss the possibility, benefits, and risks of clinical trial enrollment with their breast cancer patients. Physicians who spent the most time in patient care were least likely to discuss clinical trials with their patients. Distance from a physician's practice to the nearest clinical trial site was inversely associated with referral and recruitment. Perceived barriers to clinical trial participation were associated with greater referral activity suggesting that physicians who were more involved in trials were also more likely to understand barriers to participation.
Multilevel interventions may be successful at increasing participation of women in clinical trials.
患者参与癌症临床试验对于医学科学的发展至关重要。医生在招募患者参与临床试验方面发挥着重要作用,他们可以与癌症患者讨论临床试验。医患讨论受到许多因素的影响,这些因素与医生、患者和医疗体系有关。
从 2008 年至 2009 年的美国医学协会医师主文件中选择在加利福尼亚州、佛罗里达州、伊利诺伊州或纽约州行医、专门从事肿瘤内科、外科或放射肿瘤学的医生,对他们在乳腺癌临床试验方面的态度和实践进行调查。根据美国外科医师学院提供的分类,将实践类型进行分类,并对临床试验和实践地址进行地理编码。
在符合条件的 1534 名医生中,有 706 名(46%)完成了调查。肿瘤内科医生比外科或放射肿瘤医生更有可能与乳腺癌患者讨论临床试验参与的可能性、益处和风险。花最多时间在患者护理上的医生最不可能与患者讨论临床试验。医生的实践地点与最近的临床试验地点之间的距离与转诊和招募呈反比。参与临床试验的障碍与更高的转诊活动有关,这表明参与临床试验的医生更了解参与障碍。
多层次干预措施可能成功增加女性参与临床试验的人数。